IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
    • Annual General and Special Shareholders Meeting
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact

Press Releases

Investors

Investors

  • Overview
  • Press Releases
  • Events, Webcasts & Presentations
    • Overview
    • Presentations
    • Scientific Publications & Posters
    • Email Alerts
  • Financial Info
    • Financial Results
    • Tax Info
    • Proxy Info
    • Stock Option Plan
    • Deferred Share Unit Plan
  • Stock Data
    • NASDAQ: IMV
    • TSX: IMV
    • Analyst Coverage
  • Filings
    • SEC Filings
    • SEDAR
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Contact Us
  • FAQ
May 17, 2010 8:47am EDT

Immunovaccine Appoints Paul Kirkconnell to Board

May 12, 2010 3:25pm EDT

Immunovaccine Announces 2010 First Quarter Results

Apr 22, 2010 5:49am EDT

Immunovaccine Signs Research Agreement with Dana-Farber Cancer Institute

Apr 19, 2010 5:49am EDT

Immunovaccine Announces 2009 Year End Results

Apr 05, 2010 4:49pm EDT

Immunovaccine Announces the Publication of DPX-0907 Preclinical Study

Mar 29, 2010 4:30pm EDT

Immunovaccine Begins Patient Recruitment for Phase 1 Trial of DPX-0907 Cancer Vaccine

Mar 02, 2010 8:40am EST

Immunovaccine Signs Licensing Deal with Pfizer Animal Health to Develop a Third Livestock Vaccine

Feb 23, 2010 8:30am EST

Immunovaccine Appoints James Hall as New Board Member

Feb 08, 2010 8:56am EST

Immunovaccine Presents Results for an Enhanced Anthrax Vaccine Candidate

Feb 04, 2010 8:45am EST

Immunovaccine Provides Corporate Update

RSS
  • Prev
  • 1...
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • Next
  • Email Alerts
  • Contacts
  • RSS News Feed
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2022 IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap